- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0072618

About Stemrx Bioscience Solutions Private Limited
Data last updated:
Stemrx Bioscience Solutions Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 13 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U93030MH2014PTC253238. Its GSTIN is 27AAUCS3062R1ZD (Maharashtra).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.28 Lakh. It is led by directors including Neetin Shivajirao Desai and Pradeep Venkatrao Mahajan.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.63 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹50.83 Lakh (net margin 3.7%) and EBITDA of ₹2.03 Cr (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 10% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 4 brands: Stemrx Biosciences, OrbisX, Stemrx Bioscience and Vrozart Health. As per MCA filings, the company has open charges of ₹20 Lakh on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.
Stemrx Bioscience Solutions Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0072618). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stemrx.in.
Company details
Recognitions & Rankings of Stemrx Bioscience Solutions
Contact details
Stemrx Bioscience Solutions Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is stemrx.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFirst Floor R – 831 Dr. Mahajan Hospital T C Rabale Thane Belapur Rd., Navi Mumbai, Maharashtra, India – 400708
- IndustryLife Sciences, Biotechnology
To see the full contact details of Stemrx Bioscience Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Stemrx Bioscience Solutions operates multiple associated brands including Stemrx Biosciences, OrbisX, and Stemrx Bioscience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| StemRx Biosciences develops regenerative medicine and sells herbal supplements online. | stemrxbiosciences.in | |
| CRM software for automotive detailers and tinters to manage bookings, inventory, and communications. | orbisx.com | |
| Regenerative medicine and nutraceutical supplements in India. | stemrxbiosciences.com | |
| Provider of medical tourism services | vrozarthealth.com |
Business activity
The main business activity of Stemrx Bioscience Solutions is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Stemrx Bioscience Solutions Private Limited, buy the company report.
Financials of Stemrx Bioscience Solutions Private Limited
FY 2025 filings availableStemrx Bioscience Solutions Private Limited reported revenue of ₹13.63 Cr (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.03 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹50.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stemrx Bioscience Solutions Private Limited, buy the company report.
Board of directors of Stemrx Bioscience Solutions Private Limited
Stemrx Bioscience Solutions has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neetin Shivajirao Desai | Director | 13 Feb 2014 | 12 Years 9 Months | Current |
| Pradeep Venkatrao Mahajan | Director | 13 Feb 2014 | 12 Years 9 Months | Current |
| Vipula Pradeep Mahajan Also directs: Venkateshwara Heights Limited Liability Partnership, Stemrx Medical Device LLP, Ridgeline Developers Private Limited and 5 more | Director | 13 Feb 2014 | 12 Years 9 Months | Current |
Auditor
Stemrx Bioscience Solutions Private Limited is audited by MANOJ H JAISWAL for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ H JAISWAL | FY 2022 | 150561 |
Shareholding
The shareholding of Stemrx Bioscience Solutions Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stemrx Bioscience Solutions Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Aug 2015 | 100029438 | Idbi Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Stemrx Bioscience Solutions Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Funding round | ₹2 Cr | Investors: Birthstone Capital |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Stemrx Bioscience Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stemrx Bioscience Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Stemrx Bioscience Solutions Private Limited has a workforce of 6 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 6 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Stemrx Bioscience Solutions Private Limited, buy the company report.
GST
Stemrx Bioscience Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAUCS3062R1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stemrx Bioscience Solutions Private Limited, buy the company report.
Recent activity
Stemrx Bioscience Solutions Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Aken Jatin Sanghavi ceased to be Additional Director on 18 Nov 2022.
Frequently asked questions
Stemrx Bioscience Solutions is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 13 February 2014 (12+ years old) and is registered under CIN U93030MH2014PTC253238.
Stemrx Bioscience Solutions has 3 current directors:
- Neetin Shivajirao Desai - Director
- Pradeep Venkatrao Mahajan - Director
- Vipula Pradeep Mahajan - Director
The latest financial statements of Stemrx Bioscience Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stemrx Bioscience Solutions is 27AAUCS3062R1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Stemrx Bioscience Solutions is U93030MH2014PTC253238. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stemrx Bioscience Solutions was incorporated on 13 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Stemrx Bioscience Solutions has 1 deal on record (1 funding round), with disclosed funding of ₹2 Cr; the latest was in August 2020.
Aken Jatin Sanghavi ceased to be Additional Director on 18 Nov 2022. Siddhant Pradeep Mahajan ceased to be Director on 18 Oct 2021. Vijay Gopal Pandhare ceased to be Director on 03 Sep 2015. Stemrx Bioscience Solutions has 6 board changes on record in total.
Yes, Stemrx Bioscience Solutions is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0072618).
Stemrx Bioscience Solutions can be reached through the website stemrx.in. Its registered office is in Navi Mumbai, Maharashtra, India.

